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Introduction
Diabetic retinopathy (DR) is a leading cause of  blindness in the working-age population (1, 2). It is char-
acterized by a progressive dysfunction of  the retinal neurons, glial cells, and microvasculature, leading 
to abnormal vessel proliferation and vascular leakage that threaten vision (3). Although the pathological 
hallmarks of  DR are well defined, how sustained hyperglycemia leads to retinal neurovascular dysfunc-
tion remains to be elucidated. The pathogenesis of  DR is complex and driven by a multitude of  factors in 
addition to hyperglycemia, including oxidative stress, dyslipidaemia, and chronic parainflammation (4). 
Current therapies for DR remain unsatisfactory and focus mainly on targeting the end-stages of  the disease 
process (5). Consequently, there is an urgent need to develop new interventions — particularly those that 
are able to prevent the initiation and development of  this condition.
A growing body of  evidence suggests that mitochondrial dysfunction plays a pivotal role in the early 
pathogenesis of  DR. For example, mitochondrial DNA (mtDNA) damage, mitochondrial overproduction 
of  ROS, and inefficient mtDNA repair mechanisms have been implicated both in the human diabetic retina 
and animal models of  DR (6). At the ultrastructural level, mitochondrial damage in retinal endothelial 
cells and neurons during DR is evidenced by the presence of  vacuolated mitochondria with disruption of  
the lamellar cristae (7). Mitochondrial changes have also been observed in retinal cell cultures maintained 
under hyperglycemia, as shown by increased mitochondrial fragmentation and reduced oxygen consump-
tion rates (8). The accumulation of  damaged mitochondria disrupts normal tissue homeostasis and leads to 
exacerbated oxidative stress, energy deficits, and eventual cell apoptosis (9).
Mitochondrial quality control (MQC) is crucial for regulating CNS homeostasis, and its disruption 
has been implicated in the pathogenesis of some of the most common neurodegenerative 
diseases. In healthy tissues, the maintenance of MQC depends upon an exquisite balance between 
mitophagy (removal of damaged mitochondria by autophagy) and biogenesis (de novo synthesis 
of mitochondria). Here, we show that mitophagy is disrupted in diabetic retinopathy (DR) and 
decoupled from mitochondrial biogenesis during the progression of the disease. Diabetic retinas 
from human postmortem donors and experimental mice exhibit a net loss of mitochondrial 
contents during the early stages of the disease process. Using diabetic mitophagy-reporter mice 
(mitoQC-Ins2Akita) alongside pMitoTimer (a molecular clock to address mitochondrial age dynamics), 
we demonstrate that mitochondrial loss arose due to an inability of mitochondrial biogenesis to 
compensate for diabetes-exacerbated mitophagy. However, as diabetes duration increases, Pink1-
dependent mitophagy deteriorates, leading to the build-up of mitochondria primed for degradation 
in DR. Impairment of mitophagy during prolonged diabetes is linked with the development of 
retinal senescence, a phenotype that blunted hyperglycemia-induced mitophagy in mitoQC primary 
Müller cells. Our findings suggest that normalizing mitochondrial turnover may preserve MQC and 
provide therapeutic options for the management of DR-associated complications.
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The maintenance of  a healthy mitochondrial network within cells depends upon mitochondrial quality 
control (MQC) mechanisms, which regulate the balance between mitophagy (autophagic removal of  dam-
aged mitochondria) and biogenesis (de novo synthesis of  mitochondria) (10). Mitophagy typically occurs in 
damaged mitochondria upon dissipation of  the mitochondrial membrane potential (ψm), leading to stabi-
lization of  Pink1 at the outer mitochondrial membrane (OMM). This primes mitochondria for autophagy 
via activation of  the E3-ubiquitin ligase Parkin (11, 12). Mitochondrial biogenesis is a dynamic process that 
is regulated in response to cellular metabolic demands and increases following the induction of  mitophagy 
(13). Although several effectors are involved, PGC-1α and mitochondrial transcription factor A (TFAM) 
are critical in driving the replication of  mtDNA and synthesis of  proteins encoded in its genome (13).
The disruption of  MQC has recently been implicated as a major cause of  neurovascular pathology in 
a number of  neurodegenerative disorders, including Parkinson’s and Alzheimer’s diseases (14). Here, we 
show for the first time to our knowledge that mitophagy is dysregulated and uncoupled from mitochondrial 
biogenesis during the progression of  DR.
Results
Mitochondrial contents change during the progression of  DR in human and murine retinas. We first investigated 
mitochondrial contents in human retinas from nondiabetic (ND) subjects, from people with diabetes but 
no retinopathy (DNR), and from people with DR, using Cox4 antibody. Overall, compared with ND, Cox4 
levels were lower in DNR but elevated in DR (Figure 1A). Quantitative analysis of  Cox4 in specific retinal 
layers of  DNR subjects revealed a significant reduction within synaptic processes of  the outer plexiform 
layer (OPL) as compared with ND (Figure 1, B and C). Cox4 was also significantly reduced in the inner 
segments (IS) of  cone photoreceptors in DNR (Figure 1B), further revealing mitochondrial morphological 
alterations in DNR subjects, including mitochondrial redistribution throughout the IS (Figure 1D) and 
abnormal fragmentation (Figure 1D). No changes were observed in Cox4 levels at the inner plexiform 
layer (IPL) of  DNR (Figure 1B). Interestingly, Cox4 contents were not reduced in DR subjects, displaying 
instead a significant increase in OPL and IPL (Figure 1, A–C).
To provide a basis for better understanding why mitochondrial contents shift during the course of  dia-
betes, we examined whether these changes are recapitulated in a preclinical model of  type-1 diabetes. Cox4 
levels were investigated in 2- and 8-month-old hyperglycemic Ins2Akita/+ mice, which exhibit mild to severe 
retinal neurovascular dysfunction at these time points, respectively (15–17). Cox4 immunoblots revealed loss 
of  mitochondrial contents in 2-month hyperglycemic Ins2Akita/+ mice (Figure 2A). Immunohistochemical 
analysis revealed a specific decrease of  Cox4 at the outer (IS-OPL) but not inner retinal layers (from inner 
nuclear [INL] to ganglion cell layer [GCL]; Figure 2, B and D). In contrast, Cox4 contents were unaffected 
in 8-month-old hyperglycemic Ins2Akita/+ mice (Figure 2, A, C, and E). This change of  mitochondrial contents 
at the outer retina of  Ins2Akita/+ mice included photoreceptors (as assessed specifically in IS and OPL layers; 
Supplemental Figure 1; supplemental material available online with this article; https://doi.org/10.1172/jci.
insight.129760DS1) and Müller cells, given the enrichment of  mitochondria within glutamine synthase–pos-
itive processes across the ONL (Supplemental Figure 2). Taken together, our data suggest that mitochondrial 
contents decline at the outer retina of  human and Ins2Akita/+ mice at the early stages of  diabetes but increase 
during the development of  DR. This was clearly established using immunostaining against TOMM20 (a 
translocator of  the OMM), which delineated the whole mitochondrial network at the outer retina (Figure 2, 
F–I).Moreover, no changes of  Cox4 mRNA levels (Cox4i1 and Cox4i2 isoforms) were detected in 2-month and 
8-month-old hyperglycemic Ins2Akita/+ retinas (as compared with age-matched controls, Supplemental Figure 
3), suggesting that mitochondrial changes occur due to an altered mitochondrial turnover in diabetes.
Exacerbated mitophagy occurs in Ins2Akita/+ retinas at early stages of  diabetes. To determine why mitochondrial 
contents are reduced at the early stages of  diabetes, we investigated mitochondrial biogenesis and mitoph-
agy in 2-month-old hyperglycemic Ins2Akita/+ retinas. Mitochondrial biogenesis was evaluated by assessing 2 
of  the main effectors that regulate mtDNA transcription — namely, PGC-1α and TFAM (13). No signifi-
cant changes in the protein levels of  PGC-1α were observed in 2-month-old hyperglycemic Ins2Akita/+ retinas 
(Supplemental Figure 4, A–C). TFAM immunostaining in WT mice revealed enrichment of  mitochondrial 
nucleoids (where mtDNA is packaged into discrete mtDNA-protein complexes) (18) throughout the retina, 
but no significant changes in their density were observed at the IS-OPL (Supplemental Figure 4, D–F). In 
addition, no mtDNA damage (Supplemental Figure 4G) or variations in mtDNA copy number (Supple-
mental Figure 4H) were detected, supporting the absence of  changes in mitochondrial biogenesis.
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To unambiguously investigate mitophagy in the diabetic retina, we generated Ins2Akita mitophagy- 
reporter mice (mitoQC+/– Ins2Akita/+), by mating mitoQC+/+ (19) with Ins2Akita/+ mice (Figure 3A). In line with 
a recent report (19), mitophagy was mostly detected at the outer retina, as verified by high mitolysosome 
density (mCherry-only foci) in the IS-OPL of  ND mitoQC+/– Ins2+/+ mice (Figure 3A). Diabetes amplified 
mitophagy at the outer retina, as indicated by a significant increase of  mitolysosomes in 2-month hypergly-
cemic mitoQC+/– Ins2Akita/+ mice (Figure 3, A and B). These findings were further supported by analysis of  
Pink1 (a primary effector for the autophagic degradation of  mitochondria in lysosomes; ref. 11) in retinal 
lysates (Figure 3, C–F). In healthy polarized mitochondria, Pink1 (full-length Pink1; FL-Pink1) shuttles 
to the mitochondrial matrix and is rapidly cleaved by presenilin-associated rhomboid-like protein (PARL) 
into N-terminal–cleaved Pink1 (ΔN-Pink1) (20). However, upon dissipation of  Ψm, the internalization of  
FL-Pink1 within mitochondria is prevented, and it stabilizes at the OMM, triggering the onset of  mitophagy. 
Consistent with the increased levels of  mitophagy in diabetic retinas, Pink1 levels were shifted toward its 
immature form, as shown by a significant elevation in the FL-Pink1/ΔN-Pink1 ratio (Figure 3, C–E). Fur-
ther validation was carried out by immunohistochemical approaches. As an index of  Pink1-dependent mito-
phagy, we assessed the percentage of  Pink1+ puncta colocalizing with LAMP1+ lysosomes, and it was found 
to increase in the outer retina of  2-month hyperglycemic Ins2Akita/+ mice (Supplemental Figure 5). Mitophagy 
depends on an efficient autophagic flux, and this appeared to be increased at the outer retina of  2-month-old 
hyperglycemic Ins2Akita/+ mice (based on similar Lc3b+ autophagosomes but reduced levels of  the autophagy 
substrate p62/SQTSM1; Supplemental Figure 6, A, B, E, F, I, and J) (21). Overall, our data strongly suggest 
that exacerbated Pink1-dependent mitophagy (together with normal mitochondrial biogenesis) underlies the 
reduction of  mitochondrial contents at the outer retina of  Ins2Akita/+ mice during the early stages of  diabetes.
Mitochondrial biogenesis fails to compensate for hyperglycemia-induced mitophagy in cultured retinal Müller cells. 
To determine in detail how mitochondrial turnover is affected by the diabetic milieu, the interplay between 
mitophagy and mitochondrial biogenesis was investigated under hyperglycemic conditions in vitro. Müller 
cells were selected for this study given (a) the predominant role of  mitochondrial oxidative phosphorylation 
to maintain Müller basal functions (22), (b) the recognized importance of  Müller cells in the pathogenesis 
of  DR (23), and (c) the uniform distribution of  mitochondria in Müller cells throughout the entire thickness 
of  the neuroretina (24). To address mitophagy, we took advantage of  primary Müller cells (PMCs) isolat-
ed from mitoQC mice. The purity of  mitoQC-PMCs was confirmed by glutamine synthase immunostaining 
(Figure 4A) (25). The induction of  mitophagy in mitoQC-PMCs was initially validated by HBSS amino acid 
starvation, which significantly exacerbated the density of  mitolysosomes (Figure 4A) (26). MitoQC-PMCs 
maintained in high glucose (HG; 30.5 mM D-glucose) showed a significant increase of  mitolysosomes, as 
compared with normal glucose (NG; 5.5 mM D-glucose) controls (Figure 4A). Interestingly, mitophagy was 
also elicited by hyperosmolar changes, as observed in 30.5 mM L-glucose (LG) cultures (Figure 4A). The 
induction of  mitophagy by HG and LG was corroborated in the human Müller cell line Moorfields/Institute 
of  Ophthalmology- Müller 1 (MIO-M1) by colocalization analysis of  Cox4 with Lc3b+ autophagosomes (26) 
(Figure 4B). MIO-M1 cultures maintained under HG or LG for 5 consecutive days exhibited a significant 
increase in Cox4/Lc3b colocalization (Figure 4B), suggestive of  increased mitophagy. To further substantiate 
this result, chloroquine was used to block autophagosome fusion with lysosomes (thus allowing the accu-
mulation of  mitochondria within autophagosomes). In line with an increased mitophagy flux, chloroquine 
further exacerbated the density of  Cox4/Lc3b colocalizing particles in HG and LG MIO-M1 cultures (as 
compared with NG chloroquine-treated cultures; Figure 4B).
Since our in vivo data suggest a role for Pink1 in diabetes-induced mitophagy (Figure 3, C–E), we next 
evaluated the involvement of  this pathway in HG- and LG-mediated mitophagy. Suggestive of  increased 
Pink1-dependent mitophagy, MIO-M1 cultures maintained in HG showed a significant stabilization of  
FL-Pink1 (Figure 4C) and a significant elevation in the FL-Pink1/ΔN-Pink1 ratio (data not shown). Sim-
ilar results were found in MIO-M1 cultures maintained in LG (Figure 4C). Interestingly, the levels of  the 
cleaved product ΔN-Pink1 were significantly higher in LG when compared with HG cultures (Figure 4C). 
This result led us to hypothesize that ΔN-Pink1 levels in LG may remain constant via an increase in the 
number of  hyperpolarized mitochondria and upregulation of  PARL (which would allow the steady cleav-
age of  FL-Pink1 within the mitochondrial matrix). As suggested, the contents of  PARL (Figure 4C) and 
hyperpolarized mitochondria (JC-1 red fluorescence, Figure 4D) were increased in LG MIO-M1 cultures. 
By contrast, HG cultures, which showed a decrease in ΔN-Pink1, lacked such compensation, as reflected by 
the unchanged contents of  PARL and hyperpolarized mitochondria (Figure 4, C and D).
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Figure 1. Cox4+ mitochondrial contents shift during the progression of diabetes in human retinas. (A) Retinal micro-
graphs of human retinas from nondiabetic (ND), diabetic with no retinopathy (DNR), and diabetic retinopathy (DR) 
individuals processed for Cox4 immunostaining. (B) The mean fluorescence intensities (MFI) of Cox4 in photoreceptor 
IS, OPL, and IPL of ND (n = 3 eyes), DNR (n = 5 eyes), and DR (n = 2 eyes) individuals (n = 16 technical replicates per 
donor eye were used). Data are presented in box-and-whisker plots. (C and D) Retinal micrographs from ND, DNR, and 
DR individuals processed for Cox4 and cone arrestin immunostaining in (C) photoreceptor synaptic terminals and (D) 
photoreceptor IS. (C) Loss (open arrowheads) and gain (closed arrowheads) of mitochondrial contents in cone photo-
receptor synaptic terminals. (D) Redistribution (arrow) and fragmentation (arrowheads) of Cox4+ mitochondria in cone 
photoreceptor IS. **P < 0.01, ***P < 0.001. One-way ANOVA with Bonferroni’s correction for multiple comparisons. 
IS, photoreceptor inner segments; ONL, outer nuclear layer; OPL, outer plexiform layer; IPL, inner plexiform layer; GCL, 
ganglion cell layer. Scale bars: 40 μm (A), 10 μm (C and D).
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The above results suggest that HG and LG accelerate mitophagy but only in the case of  LG is 
this compensated by an increase in mitochondrial biogenesis. This idea was tested further by studying 
mitochondrial biogenesis. BrDU incorporation into mtDNA (comprising the gold-standard for eval-
uating mitochondrial biogenesis) (27) was unchanged in MIO-M1 cultures subjected to HG (Figure 
5, A, B, and D). This was validated at the molecular level, since the contents of  molecular adaptors 
controlling mitochondrial biogenesis, including PGC-1α (total, Figure 5, E and F; nuclear, Figure 5, I, 
J, and L) and TFAM (Figure 5, E and G), remained unaltered. In comparison with HG, LG cultures 
exhibited increased mitochondrial biogenesis, as shown by the increased incorporation of  BrDU into 
mtDNA (Figure 5, A–D), upregulated levels of  nuclear PGC-1α (Figure 5, I–L), and an apparent 
increase of  TFAM (Figure 5, E and G).
Figure 2. Mitochondrial contents shift during the progression of diabetes in Ins2Akita/+ mouse retinas. (A) Example immunoblot and quantification of 
Cox4 in retinal lysates of 2-month and 8-month hyperglycemic Ins2Akita/+ and age-matched WT mice. Data were normalized to β-actin loading controls. 
(B and C) Retinal micrographs of 2-month (B) and 8-month (C) hyperglycemic Ins2Akita/+ and age-matched WT mice processed for Cox4 immunostain-
ing. (D and E) The mean fluorescence intensities (MFI) of Cox4 at the IS-OPL and INL-GCL of 2-month (D) and 8-month (E) hyperglycemic Ins2Akita/+ and 
age-matched WT mice. (F and G) Retinal micrographs of 2-month (F) and 8-month (G) hyperglycemic Ins2Akita/+ and age-matched WT mice processed for 
TOMM20 immunostaining. (H and I) The densities of TOMM20+ mitochondria at the IS-OPL of 2-month (H) and 8-month (I) hyperglycemic Ins2Akita/+ and 
age-matched WT mice. WT (white bars), Ins2Akita/+ (gray bars); n = 5–8 eyes per strain. Results presented as mean ± SEM. *P < 0.05, **P < 0.01, 2-sided 
unpaired Student’s t test. IS, photoreceptor inner segments; ONL, outer nuclear layer; OPL, outer plexiform layer; IPL, inner plexiform layer; GCL, ganglion 
cell layer. Scale bar: 40 μm (B and C), 20 μm (G).
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To confirm differences in the balance between mitochondrial biogenesis and mitophagy, we assessed 
the relative age of  mitochondria. MIO-M1 cultures were transfected with pMitoTimer (28), and the ratio 
of  red (old) vs. green (young) fluorescent mitochondria was determined (the smaller the ratio, the younger 
mitochondrial network). Compared with HG, LG cultures were expected to have younger mitochondrial 
populations, due to accelerated mitochondrial synthesis/degradation. Accordingly, LG but not HG cultures 
exhibited a significant decrease in pMitoTimer red/green (R/G) ratio (Supplemental Figure 7). Collectively, 
these data suggest that HG activates mitophagy through a pathway involving hyperosmotic stress. In con-
trast, the inability of  mitochondrial biogenesis to compensate for increased HG-induced mitophagy appears 
to result from a metabolic rather than hyperosmotic effect. These findings may explain the loss of  mitochon-
drial contents observed in the diabetic retina (Figure 1 and Figure 2) and in MIO-M1 cultures maintained 
under hyperglycemia (Cox4 immunoblots; Figure 5, E and H).
Mitophagy is impaired in Ins2Akita/+ retina at advanced stages of  neurovascular dysfunction. To understand 
the shift toward increasing mitochondrial contents at advanced stages of  DR (Figure 1 and Figure 2), 
we investigated mitochondrial biogenesis and mitophagy in 8-month-old hyperglycemic Ins2Akita/+ mice. 
In contrast to younger ages, the mitochondrial biogenesis machinery was shown to be impaired at this 
stage, as indicated by a decrease in TFAM protein levels and of  TFAM+ mitochondrial nucleoids at the 
IS-OPL (Figure 6, A–F), substantial mtDNA damage (Figure 6G), and reduced mtDNA copy num-
ber (Figure 6H). Upregulated mitochondrial biogenesis cannot, therefore, explain the normalization of  
Cox4 levels observed in 8-month-old hyperglycemic Ins2Akita/+ mice.
Importantly, the analysis of  mitophagy revealed a significant decrease of  mitolysosomes at the 
outer retina of  8-month-old hyperglycemic mitoQC+/– Ins2Akita/+ mice (as compared with ND mitoQC+/– 
Ins2+/+, Figure 7, A and B). However, FL-Pink1 stabilization and Parkin levels were strikingly increased 
(Figure 7, C–E), suggesting that Pink1-primed mitochondria are ineffectively cleared and accumulate 
in the retina at advanced stages of  diabetes. This was further evidenced by a significant accumula-
tion of  ubiquitin and p62 in the mitochondria of  photoreceptor IS; however, this was not observed in 
younger diabetic stages with competent mitophagy (Supplemental Figure 8). Autophagy adaptors were 
also found to accumulate at the outer retina, indicated by increased Lc3b+ autophagosomes and p62/
SQTSM1 (Supplemental Figure 6, C, D, and G–J). Importantly, the gene transcripts of  those mitophagy 
Figure 3. Increased mitophagy at the outer retina of 2-month hyperglycemic Ins2Akita/+ mice. (A) Confocal photomicrographs showing mitolysosomes 
(mCherry-only foci, arrowheads) at the IS-OPL of 2-month hyperglycemic mitophagy reporter mice (mitoQC+/– Ins2Akita/+) and nondiabetic siblings (mitoQC+/– 
Ins2+/+). (B) Mitolysosome density at the IS-OPL. mitoQC+/– Ins2+/+ (white bars), mitoQC+/– Ins2Akita/+ (gray bars). (C–F) Example immunoblot (C) and 
quantification of Pink1-dependent mitophagy proteins in retinal lysates (D–F) of 2-month hyperglycemic Ins2Akita/+ and age-matched WT mice. Data were 
normalized to β-actin loading controls. n = 3–7 eyes per strain. Results presented as mean ± SEM. *P < 0.05, **P < 0.01, 2-sided unpaired Student’s t test. 
IS, photoreceptor inner segments; OLM, outer limiting membrane, ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner 
plexiform layer; GCL, ganglion cell layer. Scale bar: 40μm
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(Pink1, Park2) (Figure 7, F and G) and autophagy (Map1lc3b, sqstm1) (Supplemental Figure 6K) effectors 
were unchanged in the diabetic retina at this stage, suggesting that their accumulation at the protein lev-
el was due to inefficient autophagy/mitophagy. To confirm this hypothesis, we evaluated the levels of  
mitochondria entering (a) autophagosomes (Cox4/Lc3b colocalization) and (b) Pink1-dependent mito-
phagy (Pink1/LAMP1 colocalization). The levels of  mitochondria colocalizing with Lc3b+ autophago-
somes were significantly increased at the outer retina (Supplemental Figure 9, A and C); however, their 
degradation by lysosomes appeared impaired as the levels of  Pink1 colocalizing with LAMP1 were not 
Figure 4. The diabetic milieu dysregulates mitophagy in primary Müller and MIO-M1 cultures in vitro. (A–D) Primary retinal Müller cells isolated from 
mitoQC+/+ mouse (mitoQC-PMCs) (A) or human MIO-M1 cells (B–D) were maintained for 5 days in normal glucose (NG, 5.5mM), high glucose (HG, 30.5mM), 
or L-glucose (LG, 30.5 mM) osmotic control. (A) mitoQC-PMCs had a flattened-elongated shape (bright-field image) and were positive for glutamine 
synthase (GS) immunoreactivity. Mitolysosome density (mCherry-only foci, arrowheads) was evaluated as index of mitophagy flux. Positive controls were 
established following amino acid starvation with HBSS (16 hours). Data are presented in box-and-whisker plots; n = 3–5 biological replicates per group. (B) 
Quantification of Cox4/Lc3b colocalizing particles in different treatment groups ± 100 μM chloroquine for final 12 hours of treatment. Data presented as 
fold-change vs. NG control cells in box-and-whisker plots; at least 70 cells are included, obtained from n = 3 biological replicates per group. (C) Example 
immunoblot and quantification of Pink1-dependent mitophagy proteins in different treatment groups. Data were normalized to β-actin or α-tubulin load-
ing controls; n = 3 biological replicates per group. Pink1 lanes and corresponding β-actin loading controls were run on the same gel but were noncontiguous. 
(D) Evaluation of mitochondrial membrane potential by JC-1 dye (red, hyperpolarized mitochondria; green, depolarized mitochondria) in different treatment 
groups. CCCP (20 μM) was added as a mitochondrial uncoupler positive control (16 hours); n = 3–4 biological replicates per group. Results presented as 
mean ± SEM in A, C, and D. *P < 0.05, **P < 0.01. One-way ANOVA with Bonferroni’s correction for multiple comparisons; MFI, mean fluorescence intensi-
ty. Scale bar: 100 μm (A, bright-field), 20 μm (A, mCherry-GFP; D), 2 μm (B).
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elevated (Supplemental Figure 9, B and D). Thus, disruption of  Pink1 mitophagy may contribute to the 
build-up of  mitochondria primed for degradation during advanced stages of  DR.
Disruption of  mitophagy in the diabetic retina is associated with increased cellular senescence. Mitophagy is 
known to be perturbed in senescent cells, which may result in the accumulation of  damaged mitochon-
dria (29, 30). Hence, we finally investigated whether the impairment of  mitophagy at advanced stages 
Figure 5. The diabetic milieu dysregulates mitochondrial biogenesis in MIO-M1 cultures in vitro. MIO-M1 cells were 
maintained for 5 days in normal glucose (NG, 5.5 mM), high glucose (HG, 30.5 mM), or L-glucose (LG, 30.5 mM) osmotic 
control. (A–D) Representative confocal micrographs (A–C) and quantification (D) of mitochondrial biogenesis by incor-
poration of Bromodeoxyuridine (BrDU) into mtDNA (arrowheads) in different treatment groups; data are presented in 
box-and-whisker plots. At least 70 cells were used, obtained from n = 3 biological replicates per group. (E–H) Example 
immunoblot (E) and quantification (F–H) of mitochondrial biogenesis proteins in different treatment groups. Data 
were normalized to β-actin loading control; n = 3 biological replicates per group. PGC-1α lanes and corresponding β-actin 
loading controls were run on the same gel but were noncontiguous. PGC-1α shared similar β-actin loading controls to 
those in Figure 4C (Pink1). (I–K) Representative confocal micrographs of PGC-1α immunostaining in different treatment 
groups. (L) Quantification of nuclear PGC-1α mean fluorescence intensity (MFI) in different treatment groups; n = 3 
biological replicates per group. Results presented as mean ± SEM in F–H and L. *P < 0.05, **P < 0.01. One-way ANOVA 
with Bonferroni’s correction for multiple comparisons. Scale bars: 10 μm.
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of  diabetes is associated with a senescent retinal phenotype. In support of  this, upregulated senescence- 
associated β-galactosidase (SA-β-Gal) activity (31) was observed at the outer retina of  8-month-old but 
not 2-month-old hyperglycemic Ins2Akita/+ mice (Figure 8, A–C). To further understand whether diabe-
tes-induced mitophagy may be impaired by cellular senescence, replicative, nonchemical senescence was 
induced in mitoQC-PMCs (by continuous passage [P] of  the cells until P5–P6) and mitophagy elicited by 
HG, LG, or HBSS. Senescence was confirmed in P5–P6 mitoQC-PMCs cultures, as shown by exacerbated 
SA-β-Gal activity, an enlarged/flat morphology, and negligible nuclear levels of  the proliferative marker 
Ki67 (Figure 8D). In contrast to earlier passages, mitophagy was not elicited in senescent mitoQC-PMCs 
following treatments with HG, LG, or HBSS (Figure 8, E and F). Hence, the premature senescence of  
cells at the outer retina may explain the disruption of  mitophagy at advanced stages of  diabetes.
Discussion
Our study has demonstrated how MQC becomes dysregulated in the retina during the progression of  dia-
betes. Early stages were characterized by the net loss of  mitochondrial contents at the outer retina, as mito-
chondrial biogenesis was unable to compensate for increased diabetes-induced mitophagy. However, mito-
phagy was shown to decline with diabetes duration, shifting mitochondrial contents toward normal values. 
Our data further suggest that mitophagy may be disrupted by senescence at advanced stages of  diabetes.
Figure 6. Impairment of mitochondrial biogenesis machinery in 8-month hyperglycemic Ins2Akita/+ mouse retinas. (A) Retinal micrographs from 8-month 
hyperglycemic Ins2Akita/+ and age-matched WT mice processed for PGC-1α immunostaining. (B) The mean fluorescence intensity (MFI) of PGC-1α at the 
IS-OPL. (C) Example immunoblot and quantification of PGC-1α in mouse retinal lysates of 8-month hyperglycemic Ins2Akita/+ and age-matched WT. (D) 
Retinal micrographs from 8-month hyperglycemic Ins2Akita/+ and age-matched WT mice processed for TFAM immunostaining. (E) The density of TFAM+ 
mitochondrial nucleoids at the IS-OPL. (F) Example immunoblot and quantification of TFAM in mouse retinal lysates of 8-month hyperglycemic Ins2Akita/+ 
and age-matched WT. Data were normalized to β-actin loading controls. TFAM shared similar β-actin loading controls to those in Figure 2A (Cox4). (G) 
Evaluation of mtDNA damage in 8-month hyperglycemic Ins2Akita/+ and age-matched WT mouse retinas by amplification of long (10.1 Kb) and short (116 pb) 
mtDNA regions. A reduction in the long/short amplification ratio is indicative of mtDNA damage. (H) Mitochondrial copy numbers evaluated by real-time 
PCR analysis of mMITO and CoII mtDNA regions. WT (white bars), Ins2Akita/+ (gray bars); n = 3–10 eyes per strain. Results presented as mean ± SEM. *P 
< 0.05, **P < 0.01, 2-sided unpaired Student’s t test. IS, photoreceptor inner segments; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner 
nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. Scale bars: 40μm.
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A key observation from our study involves the increased mitophagy of  the diabetic retina, which partic-
ularly affected outer retinal layers. As observed for MIO-M1 cultures maintained under LG, the increased 
mitophagy of  the diabetic retina may arise due to increased hyperosmotic stress. Although the mechanisms 
remain unclear, changes in cellular osmolarity have been reported to influence the turnover of  mitochon-
dria (32). Nonetheless, additional insults might also be responsible for the dysregulation of  mitophagy in 
the retina at the early stages of  diabetes. Photoreceptors are highly metabolic cells, exhibiting the highest 
contents of  mitochondria in the retina (as they rely on oxidative phosphorylation to support vision) (33). 
Since this process generates large amounts of  ROS capable of  damaging mitochondria, a greater demand 
for ROS-mediated mitophagy (34) at the outer retina might be expected. Previous studies have demon-
strated increased mitochondrial superoxide production in the diabetic retina (35), which, in turn, could 
exacerbate the mitophagy demands. The overproduction of  mitochondrial ROS in cell cultures exposed to 
hyperglycemia is also well documented (36, 37). Further studies are therefore warranted to more precisely 
understand the factors that contributed to increased mitophagy in the diabetic retina.
Our study suggests that Pink1 may contribute to retinal mitophagy; however, as recently suggested, the 
rate of  mitophagy in the retina was shown to be unaffected in Pink1–/– mice (19). Although this highlights 
a dispensable role for Pink1 in physiological conditions, our study supports an important role of  this path-
way to drive mitophagy in the diabetic context. Nonetheless, other pathways, including BNIP3L/NIX or 
TXNIP, might also be important for orchestrating mitophagy in diabetes (36, 38). Further investigations 
are thus needed to precisely map the importance of  the different mitophagy pathways in the diabetic retina, 
which extends beyond the scope of  this current study.
As shown in Ins2Akita/+ mice and in hyperglycemic MIO-M1 cultures, mitochondrial biogenesis was unable 
to compensate for increased diabetes-induced mitophagy. This lack of compensation is most likely explained by 
metabolic (rather than hyperosmotic) stress, since LG cultures counteracted mitochondrial degradation through 
upregulation of biogenesis. Since the biogenesis machinery appeared unaltered in 2-month-old hyperglycemic 
Ins2Akita/+ mice, it remains unclear why mitophagy is not appropriately counteracted at the early stages of diabe-
tes. Previous investigations have suggested the dysregulation of mitochondrial biogenesis in the diabetic retina 
may result, at least in part, to damage to mtDNA replication systems (39); however, this hallmark was observed 
Figure 7. Mitophagy is decreased at the outer retina of 8-month hyperglycemic Ins2Akita/+ mice. (A) Confocal photomi-
crographs showing mitolysosomes (mCherry-only foci, arrowheads) at the IS-OPL of 8-month hyperglycemic mitophagy 
reporter mice (mitoQC+/– Ins2Akita/+) and nondiabetic siblings (mitoQC+/– Ins2+/+). (B) Mitolysosome density at the IS-OPL. 
mitoQC+/– Ins2+/+ (white bars), mitoQC+/ Ins2Akita/+ (grey bars). (C–E) Example immunoblot (C) and quantification (D and 
E) of Pink1-dependent mitophagy proteins in retinal lysates of 8-month hyperglycemic Ins2Akita/+ and age-matched WT 
mice. Data were normalized to β-actin loading controls. (F and G) Real-time PCR analysis of Pink1 and Park2 gene tran-
scripts in the retina of 8-month hyperglycemic Ins2Akita/+ and age-matched WT mice. WT (white bars), Ins2Akita/+ (gray 
bars); n = 3–8 eyes per strain. Results presented as mean ± SEM. *P < 0.05, **P < 0.01, 2-sided unpaired Student’s t 
test. IS, photoreceptor inner segments; OLM, outer limiting membrane; ONL, outer nuclear layer; OPL, outer plexiform 
layer; INL, inner nuclear layer. Scale bars: 40 μm, 20 μm (inset).
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in Ins2Akita/+ mice only at the advanced stages of the disease. The dysregulation of mitochondrial biogenesis in 
the hyperglycemic context may have important pathophysiological consequences, including bioenergetic deficits 
due a net-loss of mitochondrial mass. On the other hand, the reduction of mitochondrial mass may reflect an 
attempt to decrease the overproduction of mitochondrial ROS in the diabetic retina and/or minimize patho-
physiological effects associated with the accumulation of damaged mitochondria, such as cGAS-STING–medi-
ated proinflammatory insult and activation of intrinsic mitochondrial apoptotic pathways (40).
Figure 8. Senescence in the diabetic retina may disrupt mitochondrial quality control. (A and B) Retinal micrographs from 2-month (A) and 8-month (B) 
hyperglycemic Ins2Akita/+ and age-matched WT mice processed for SA-β-Gal activity. Increased SA-β-Gal activity in photoreceptor IS of 8-month hyperglyce-
mic Ins2Akita/+ mice (arrowheads). (C) The levels of SA-β-Gal activity in photoreceptor IS in 8-month hyperglycemic Ins2Akita/+ and age-matched WT. Data are 
presented in box-and-whisker plots; n = 6 eyes per group. (D) Bright-field (BF) images of primary retinal Müller cells isolated from mitoQC+/+ mouse (mitoQC-
PMCs) showing their morphology, SA-β-Gal activity, and Ki67 immunostaining at passage 2 (P2) and P5. Proliferative nonsenescent mitoQC-PMCs show high 
nuclear-levels of Ki67 (P2, closed arrowheads), in contrast to senescent cultures (P5, open arrowheads). (E and F) Mitolysosome (mCherry-only foci) density 
was quantified in P5–P6 mitoQC PMCs maintained for 5 days in normal glucose (NG, 5.5 mM), high glucose (HG, 30.5 mM), or L-glucose (LG, 30.5 mM) osmotic 
control. Amino acid starvation with HBSS (16 hours) does not elicit mitophagy in senescent mitoQC PMCs; n = 2 biological replicates and 4 technical replicates 
per group. Results are presented as mean ± SEM. ***P < 0.001, 2-sided unpaired Student’s t test in C; 1-way ANOVA with Bonferroni’s correction for multiple 
comparisons in F. IS, photoreceptor inner segments; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; 
GCL, ganglion cell layer. Scale bars: 40 μm (A and B), 20 μm (D and E).
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A reduction in the rate of  mitophagy was observed at the outer retina in advanced stages of  diabetes. 
The disruption of  MQC through the impairment of  mitophagy has emerged as major cause of  CNS degen-
eration, since it may lead to the build-up of  oxidized mitochondria incompatible with tissue homeostasis 
(14). Therefore, it is not surprising that impaired mitophagy in Ins2Akita/+ mice was associated with mtDNA 
damage but also with a disease stage where advanced neurovascular degeneration has been reported (15, 
17). Whether the reduction in the rate of  mitophagy at advanced stages arises due to failure of  autophagy, 
mitophagy, or both needs further investigation. Previous studies supported the dysregulation of  autophagy 
in the diabetic retina, either suggesting an increase (41) or a deficiency (42) in the flux. Our study con-
curs with both observations, depending on the duration of  diabetes examined. In contrast to 2-month-old 
hyperglycemic Ins2Akita/+ mice where autophagy appears to be coupled with increased mitophagy flux, at 
advanced stages of  the disease, the accumulation of  Lc3b+ autophagosomes and p62/SQTSM1 may indi-
cate ineffective autophagy (21). This could arise due to a deficit of  cargo degradation in lysosomes, since 
the levels of  mitochondria entering autophagosomes were increased.
We further propose that premature senescence of  the outer retina may play an important role in the 
disruption of  MQC, which may shift mitochondrial contents to higher levels at advanced stages of  DR. 
In agreement with this, the accumulation of  dysfunctional mitochondria is a well-known hallmark of  
senescent cells (30). At present, the mechanisms initiating cellular senescence in the diabetic retina remain 
uncertain. The increase of  autophagic flux from the early stages could potentially facilitate the process of  
senescence (43). Moreover, the dysregulation of  MQC due to inefficient mitophagy may also contribute 
to this process (30). Aside from these factors, other different stressors such as genotoxic or oxidative insult 
could be relevant (44). Regardless of  its origin, the senescence of  the diabetic retina may have important 
pathological implications, such as the development of  senescence-associated secretory phenotype (SASP), 
associated with an exacerbated secretion of  proinflammatory mediators (45).
In summary, our study provides insights into the pathobiology of  DR, which may be therapeutically 
relevant for the early and advanced stages of  the disease. Therapies aimed at counteracting increased dia-
betes-induced mitophagy through stimulating mitochondrial biogenesis may be important during the early 
stages. However, this strategy could involve a risk when the efficiency of  mitophagy decreases (i.e., at more 
advanced stages), which may worsen the accumulation of  damaged mitochondria in the diabetic retina. 
While promoting mitophagy at these stages appears reasonable, future studies will determine the suitability 
of  those therapies for the management of  DR.
Methods
Animals
Male heterozygous Ins2Akita/+ mice of  C57BL/6J background (originally purchased from the Jackson Lab-
oratory) and age-matched ND siblings (WT) were used in the study. The Ins2Akita/+ mice develops severe 
hyperglycemia (above 550 mg/dL or 30.5 mM) by 4 weeks of  age (46). mitoQC+/– Ins2Akita/+ mice were gen-
erated by mating mitoQC+/+ females (provided by Ian G. Ganley, University of  Dundee, Dundee, United 
Kingdom) with Ins2Akita/+ males. The diabetic phenotype in the resultant male offspring was corroborated by 
the levels of  glucose (above 550 mg/dL or 30.5 mM) and HbA1c (diabetic mitoQC+/– Ins2Akita/+ had 113.5 ± 
4.6 mmol/mol; ND mitoQC+/– Ins2+/+ siblings had 29.7 ± 1.9 mmol/mol). Detection of  the mitoQC-knockin 
allele (mCherry-GFP-mtFIS1101–153) was determined by PCR (47).
Real-time PCR
Total RNA was isolated from Ins2Akita/+ and age-matched WT retinas (n = 6–8 retinas/group) using the RNeasy 
Mini Kit (Qiagen) and real-time PCR performed using SYBR-Green Master in a Light-Cycler 480 system 
(Roche Diagnostics). The relative expression of  target genes (Supplemental Table 1) was normalized to 18s.
Mitochondrial copy number
Total DNA from Ins2Akita/+ and age-matched WT retinas (n = 7–10 retinas/group) was extracted using the 
DNeasy Blood & Tissue Kit (Qiagen), and real-time PCR was performed using specific primers (Supple-
mental Table 1) to detect mMITO and cytochrome-c oxidase subunit II (CoII) as markers for mtDNA and 18s 
for nuclear DNA (nDNA). The mtDNA/nDNA ratio was used as measurement of  mtDNA copy number.
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mtDNA damage
Total DNA from Ins2Akita/+ and age-matched WT retinas (n = 7–10 retinas/group) was amplified by PCR 
using specific primers (Supplemental Table 1) for long (10.1 Kb) and short (116 pb) mtDNA regions (48). 
Long and short amplification products were respectively separated in 1% and 2% agarose gels, and the 
intensity of  SYBR_Safe DNA blots was quantified using FIJI software (NIH). The relative amplification 
of  the long PCR product was normalized to the short product; a reduction in the amplification ratio was 
indicative of  increased mtDNA damage (48).
Intravitreal injection of chloroquine
Autophagy flux in the retina was blocked via intravitreal administration of  1 μL chloroquine (Thermo Fisher 
Scientific; 500 μM) in 3-month-old WT mice. Injections were performed as previously reported (49). Twen-
ty-four hours following chloroquine administration, mouse eyes were collected and processed for IHC.
IHC
Human retinas. Age-matched human retinas from diabetic and ND individuals were obtained postmortem 
from the National Disease Research Interchange (Philadelphia, Pennsylvania, USA) as described (41). The 
groups were categorized as ND (n = 3 donors), DNR (n = 5 donors; type-1 diabetes [n = 3], type-2 diabetes 
[n = 2]), and diabetes with retinopathy (n = 2 donors; type-2 diabetes, nonproliferative DR). Following dep-
araffinization, retinal sections were immersed (1 hour) in antigen retrieval buffer (EDTA, pH 8.0; Thermo 
Fisher Scientific) at 60°C. Sections were then rinsed in PBS and incubated overnight (4°C) with Cox4 and 
cone arrestin antibodies (Supplemental Table 2) as previously described (50). 
Mouse retinas. Eyes were dissected, fixed in 2% paraformaldehyde (Sigma-Aldrich), and processed for 
IHC (Supplemental Table 2) as previously described (50).
Cell culture
The human Müller cell line MIO-M1 was obtained from the UCL Institute of  Ophthalmology (Lon-
don, United Kingdom; ref. 51). PMCs from mitoQC+/+ mice were isolated and cultured as previously 
described (25). PMCs were used for experiments from P2–P6, where most cells showed a senescence 
phenotype. Cultures were maintained in DMEM (containing 10% FCS [Thermo Fisher Scientific], 
100 U/mL penicillin-streptomycin [Sigma-Aldrich]) and supplemented with 5.5 mM D-glucose (NG), 
30.5 mM D-glucose (Sigma-Aldrich; HG), or 30.5 mM LG (Alfa aesar; 25 mM LG + 5.5 mM NG) 
for 5 days. The selection of  30.5 mM D-glucose was based on the levels of  hyperglycemia found in the 
plasma of  Ins2Akita/+ mice. For mitophagy-induced amino acid starvation, cultures were maintained in 
HBSS (Thermo Fisher Scientific; 16 hours). Autophagy flux was blocked with 100 μM chloroquine (12 
hours). Endpoint experiments were performed in 70%–80% confluent cultures. No mycoplasma was 
detected in the cell cultures (PCR Mycoplasma Test Kit I/C; PromoCell).
Immunocytochemistry
Cells were fixed in 2% paraformaldehyde, rinsed in PBS, and blocked (3% BSA [Sigma-Aldrich], 0.1% 
TritonX-100 [Sigma-Aldrich], PBS). Cells were then incubated overnight (4°C) with primary antibodies 
(Supplemental Table 2) diluted in 3% BSA and 0.05% Tween-20 [Sigma-Aldrich], PBS. Following incu-
bation, cells were probed (1 hours) with fluorophore-conjugated secondary antibodies (all from Jackson 
ImmunoResearch) at room temperature.
Western blotting
Retinas and MIO-M1 cells were lysed in RIPA buffer with protease and phosphatase inhibitors cocktails 
(Sigma-Aldrich). Protein samples (10–20 μg) were run on 7.5%, 10%, or 12% (w/v) SDS-PAGE gel, and 
samples were immunoblotted for primary antibodies (Supplemental Table 2). Immunoblots (obtained 
from 3 biological replicates) were quantified by densitometry, and protein expressions were normalized 
to β-actin or α-tubulin levels.
pMitoTimer transfections
pMitoTimer (Addgene) incorporates a fluorescent timer reporter to mitochondria (pDsRed2-Mito) that fluo-
resces GFP when newly synthetized and irreversibly shifts to red spectrum (excitation/emission [Ex/Em] 
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558/583 nm) over time (28). MIO-M1 cells were incubated (12 hours) with a mixture of  50 ng plasmid 
DNA and 0.15 μL endofectin (GeneCopoeia) in Opti-MEM (Thermo Fisher Scientific). Cells were then 
maintained in NG, HG, or LG and fixed for microscopy.
JC-1 dye staining
The ψm was assessed by ratiometric analysis of  JC-1 (Thermo Fisher Scientific). Following NG, HG, 
or LG treatment, MIO-M1 cultures were supplemented with 0.5 μg/mL JC-1 (30 minutes at 37°C) and 
returned to DMEM for microscopy. Positive controls were supplemented for 16 hours with carbonyl cya-
nide m-chlorophenylhydrazone (CCCP, 20 μM; Abcam) to uncouple mitochondria.
Immunolabeling BrDU DNA
Following NG, HG, or LG treatment, cultures were supplemented (12 hours) with 10 μM BrdU (Thermo 
Fisher Scientific) and fixed. Cells were then rinsed in PBS and the DNA denatured (20 min) with 0.5 M 
HCl. Cells were washed with PBS and processed for anti-BrDU immunocytochemistry.
SA-β-Gal activity
Retinal cryosections obtained from Ins2Akita/+ and WT mice (n = 6 eyes/group) and mitoQC-PMCs cultures (P2–
P3 and P5–P6) were processed following manufacturer’s instructions of the Senescence Detection Kit (Abcam).
Confocal morphometry
Confocal images were acquired under constant photomultiplier settings (C1-Nikon_Eclipse TE200-U) and 
analyzed using FIJI software. To avoid any bias during imaging, retinal regions were selected based on the 
DAPI nuclear signal and invariably, from middle-center eccentricities. For cell cultures, images were select-
ed from the same cardinal points of  the wells using bright-field imaging.
Cox4 levels in human retinal sections. Images (2 retinal sections/eye; 8 images/section) were used to quan-
tify the mean fluorescence intensity (MFI) of  Cox4. For this purpose, mean luminance values (average 
brightness per pixel) were calculated from manually traced areas, including (a) IS of  cone photoreceptors 
(identified by cone arrestin immunoreactivity), (b) OPL, and (c) IPL. Background was acquired from a 
vacant area of  the labeled section and subtracted from the raw images to eliminate background noise. The 
technical replicates (n = 16 for each eye) were used for statistical analysis.
MFI in mouse retinas. Images (n = 4–5 eyes/group; 2 retinal sections/eye; 4 images/section) were used 
to quantify the MFI values of  Cox4, PGC-1α, Lc3b, and p62/SQTSM1 in WT and Ins2Akita/+ mice. Mea-
surements were obtained (a) from the photoreceptor IS to the OPL (referred as the outer retina) and (b) 
from the INL to the GCL (referred as the inner retina). MFI values were averaged for each eye.
Ubiquitin in mitochondria of  photoreceptor IS. Images (n = 5–6 eyes/group; 2 retinal sections/eye; 4 imag-
es/section) were used to delineate mitochondrial ROIs (Fis1+ area) in photoreceptor IS. The MFI of  ubiq-
uitin immunostaining was then assessed in mitochondrial ROIs. MFI values were averaged for each eye.
Quantification of  TFAM+mitochondrial nucleoids and TOMM20+ mitochondria at the outer retina. Mitochon-
drial nucleoids and TOMM20+ mitochondria were quantified in confocal retinal images (n = 5–8 eyes/
group; 2 retinal sections/eye; 4 images/section) by threshold image binarization of  TFAM+ or TOMM20+ 
particles at the IS-OPL (constant values were applied for all groups), and their number was obtained by par-
ticle analysis in FIJI. Mitochondrial nucleoid and TOMM20+ mitochondrial values were then normalized 
to the outer retinal area analyzed. Values were averaged for each eye.
Quantification of  mitolysosomes (mCherry-only foci) at the outer retina. The total mitolysosome number in 
confocal retinal images (n = 4–8 eyes/group, 2 retinal sections/eye; 4 images/section) at the outer retina 
(IS-OPL) was determined by the subtraction of  GFP signal from mCherry using the “image calculator” 
plugin of  FIJI. This was followed by threshold image binarization of  mitolysosomes (constant values were 
applied for all groups), and the total number was obtained by particle analysis. Mitolysosome number was 
then normalized to the outer retinal area analyzed. Values were averaged for each eye.
SA-β-Gal in mouse retinas. Images (n = 6 eyes/group; 2 retinal sections/eye; 4 images/section) were 
inverted and transformed into 32-bit color to quantify the intensity of  SA-β-Gal staining in WT and Ins2Akita/+ 
mice. Measurements obtained from the IS were averaged for each eye.
Quantification of  mitolysosomes in mitoQC-PMCs. The total mitolysosome area in individual cells was 
determined by the subtraction of  GFP signal from mCherry using the “image calculator” plugin of  FIJI. 
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This was followed by threshold image binarization of  mitolysosomes (constant values were applied for all 
groups), and the total area (μm2) was obtained by particle analysis. Values (P2–P3 cells, n = 3–5 biological 
replicates per group; P5–P6 cells, n = 2 biological replicates and 4 technical replicates per group) were nor-
malized to the cellular area.
BrDU incorporation in mtDNA. The cytoplasmic area of  each individual cell was manually traced, 
inverted, and duplicated for analysis. The BrDU+ area was then delineated by threshold image binariza-
tion (using constant values for all groups), and the total area (μm2) was obtained by particle analysis. 
Values were normalized to the cellular area. At least 70 cells (obtained from n = 3 biological repli-
cates) were analyzed. The specificity of  BrDU within mitochondria was validated by costaining with 
TOMM20 (data not shown).
Ratiometric analysis of  pMitoTimer. Red- and GFP-fluorescent signals were merged and pMitoTimer ROIs 
obtained by threshold image binarization and particle analysis. Red- and GFP-fluorescent MFIs were then 
obtained from the pMitoTimer ROIs and the R/G ratio was calculated in each image. Cells obtained from n = 2 
biological replicates (5 technical replicates per group) were analyzed.
Colocalization analysis in retina. Images (n = 5 eyes/group; 2 retinal sections/eye; 2 images/section) were 
processed for colocalization analysis using the Intensity Correlation Analysis of the WCIF-ImageJ module 
(52). The total colocalizing area (μm2) was then obtained by threshold image binarization and particle analysis 
of the generated +ves stack (which shows all positive colocalizing pixels). The percentage of Cox4 or Pink1, 
respectively colocalized with Lc3b or LAMP1, was determined as = (total colocalizing area) × 100/(Cox4 [or] 
Pink1 area). For each eye, values were averaged. Pink1 antibody was validated using MitoQC+/+Pink1–/– mouse 
eyes (provided by Ian G. Ganley) (Supplemental Figure 10A). Pink1, Lc3b, and LAMP1 antibodies were fur-
ther validated for IHC via intravitreal injection of chloroquine in mouse eyes (Supplemental Figure 10, B–D).
Colocalization analysis in MIO-M1 cells. The total colocalizing area between Cox4 and Lc3b (calculated 
as above) was normalized to the cell area. Data were then referred as fold changes to NG. At least 70 cells 
(obtained from n = 3 biological replicates) were analyzed.
Statistics
In each age group, the difference between 2 means was analyzed using 2-sided unpaired Student’s t test and 
1-way ANOVA (followed by Bonferroni’s post hoc analysis) used for comparisons with more than 2 groups 
(GraphPad Prism). To compare the difference between 2 means by immunohistochemical morphometry, 
sample size was adjusted to n = 4–9 eyes in each mouse group based on an 80% power and a 5% significant 
level. Significant out-layers were discarded using Grubbs’ test (α = 0.05). Data were expressed as mean ± 
SEM. P < 0.05 was considered statistically significant.
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